FGP
ZYME icon

Freestone Grove Partners’s Zymeworks ZYME Stock Holding History

Freestone Grove Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.9K Sell
648
-12,297
-95% -$312K ﹤0.01% 884
2026
Q1 		$324K Buy
+12,945
New +$306K ﹤0.01% 674

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Freestone Grove Partners's ZYME Position: Q2 2026 in Review

Freestone Grove Partners reduced its Zymeworks (ZYME) stake by 95% in Q2 2026, selling an estimated $312K and leaving 648 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #884.

Freestone Grove Partners first reported a position in ZYME in Q1 2026 and has held it in 2 quarters since. The position peaked at $324K in Q1 2026. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Freestone Grove Partners held 648 shares of Zymeworks worth $16.9K as of Q2 2026.
  • Freestone Grove Partners sold 12,297 Zymeworks shares in Q2 2026, an estimated $312K.
  • Zymeworks made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #884 holding.
  • Freestone Grove Partners first reported a position in Zymeworks in Q1 2026 and has held it in 2 quarters since.
  • Freestone Grove Partners's Zymeworks position peaked at $324K in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.